- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
It is recommended to take Capivasortib with food to improve the stability and bioavailability of drug absorption. The specific medication plan ...
The side effects of Capivasertib mainly include digestive system reactions, skin reactions, metabolic abnormalities, etc., most of which can be...
Adagrasib is a targeted anti-cancer drug primarily used to treat non-small cell lung cancer with KRASG12C mutation. Its common side effects inc...
The standard dose of Adagrasib is 600mg twice daily (2 300mg tablets), taken at 12 hour intervals and continuously administered until disease p...
Naldemedine, as an opioid receptor antagonist, is mainly used to treat constipation caused by opioid drugs. Its side effects are mainly gastr...
Naldemedine is a specific medication used to treat opioid induced constipation (OIC) in adult patients. The standard dose is 0.2mg orally per d...
比美替尼(Binimetinib)的用药周期需根据疾病进展、耐受性及治疗效果动态调整，通常需持续用药直至疾病恶化或出现不可耐受毒性。以下从用药时长判断依据、中断标准及特殊情况下长期用药管理三方面具体说明。 1适应症 (1)黑色素瘤：与康奈非尼联用治疗BRAFV600E/K突变阳...
There are multiple restrictions on the use of Binimetinib, including contraindications for special populations, dosage adjustment requirements,...
Binimetinib is an oral MEK1/MEK2 kinase inhibitor that needs to be used in combination with Conafenib. It is mainly used to treat BRAFV600E/K m...
Binimetinib, as a MEK inhibitor, commonly has multiple systemic side effects that require different mitigation measures based on their severity...
